Northpond Ventures, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Northpond Ventures, LLC reported 4 stock positions worth $102.6 million. Its top holding was Kyverna Therapeutics (KYTX) at 78.8% of the portfolio, followed by Vigil Neuroscience (VIGL, 14.0%) and Telesis Bio (4.2%). Compared with Q4 2023, it opened 1 new position. The biggest buy was a new position in Kyverna Therapeutics (KYTX).
- Most Recent 13F
- Q3 2024
- Location
- Bethesda, MD
- CIK
- 0001911245
- Portfolio Value
- $102.6M (Q1 2024)
- SEC Filing
- 0001104659-24-061943 ↗ filed May 15, 2024
Holdings Value
Holdings 4 stocks · $102.6M
| KYTX Kyverna Therapeutics Inc. | 78.80% | 3,255,426 | $80.9M | New |
| VIGL Vigil Neuroscience Inc. | 14.00% | 4,214,498 | $14.4M | No change |
| TELESIS BIO INC | 4.22% | 9,844,130 | $4.3M | No change |
| CADL Candel Therapeutics Inc. | 2.98% | 1,935,215 | $3.1M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| KYTX Kyverna Therapeutics Inc. | New | 78.80% | +78.80 |